ArticleLeukemia2016

High CIP2A levels correlate with an antiapoptotic phenotype that can be overcome by targeting BCL-XL in chronic myeloid leukemia.

C M Lucas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.